ContextVision AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
October 20, 2022 at 04:06 am EDT
Share
ContextVision AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was SEK 25.59 million compared to SEK 26.04 million a year ago. Revenue was SEK 26.91 million compared to SEK 26.04 million a year ago. Net income was SEK 8.79 million compared to SEK 2.3 million a year ago. Earnings per share from continued operations before/after dilution was SEK 0.11 compared to SEK 0.15 a year ago.
For the nine months, sales was SEK 85.26 million compared to SEK 70.67 million a year ago. Revenue was SEK 86.58 million compared to SEK 70.67 million a year ago. Net income was SEK 21.41 million compared to net loss of SEK 3.16 million a year ago. Earnings per share from continued operations before/after dilution was SEK 0.34 compared to SEK 0.35 a year ago.
ContextVision AB is a Sweden-based medical technology software company specialized in image analysis and artificial intelligence. The Company is engaged in the image enhancement market and is a partner to the manufacturers of ultrasound, X-ray and Magnetic Resonance Imaging (MRI) equipment around the world. The Company develops software products, based on proprietary technology and artificial intelligence for image-based applications. ContextVisionâs cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The Company operates through two separate segments: the Business Unit Medical Imaging and the Business Unit Digital Pathology. ContextVision has two subsidiaries: Inify Laboratories AB og ContextVision Inc.
CONTEXTVISION AB 
